Novo Nordisk Demerges
Denmark's Novo Nordisk is demerging, to make its businesses more flexible and fast-footed.
You may also be interested in...
Ever since its pure-play biopharma strategy went into effect, Bristol-Myers Squibb has preferred buying biotechs it knows well. Hepatitis C development partner ZymoGenetics is no exception.
Progress for two US-based companies in the race to develop a COVID-19 vaccine.